Anti-CYP3A4 Recombinant Antibody Products
Loading...Anti-CYP3A4 Products
Loading...- Rabbit Anti-CYP3A4 Recombinant Antibody (clone JA11-33) (MRO-0431-CN)
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC, IP
-
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: ELISA, IHC
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG1
- Application: WB, IHC, ICC, FC, ELISA
-
- Derivation: Mouse
- Species Reactivity: Human
- Type: Mouse IgG
- Application: WB, ELISA, ICC, IF, IHC
-
- Derivation: Phage display library
- Species Reactivity: Human
- Type: Rabbit IgG
- Application: WB, IHC, IP
- Anti-CYP3A4 Immunohistochemistry Kit (VS-0325-XY610)
-
- Species Reactivity: Human
- Target: CYP3A4
- Application: IHC
- Anti-Human CYP3A4 Immunohistochemistry Kit (VS-0525-XY1875)
-
- Species Reactivity: Human
- Target: CYP3A4
- Application: IHC
Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag
Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us
For Research Use Only. Not For Clinical Use.
Creative Biolabs is your expert partner in pharmacology. Our elite anti-CYP3A4 recombinant antibodies are the highest quality tools for studying drug-drug interactions, pharmacokinetics and clinical trial success.
CYP3A4: The Most Important Human Drug Metabolizer
Cytochrome P450 3A4 (CYP3A4) is a monooxygenase enzyme present in the endoplasmic reticulum of the liver and small intestine. It is the most abundant of the human CYP enzymes and it catalyzes the phase I metabolism of nearly 50% of all prescription drugs, including statins, macrolide antibiotics, and benzodiazepines. CYP3A4 can accept a wide range of substrates due to its large, flexible active site. Due to its high potential for drug-drug interactions (DDI) and its extensive genetic variability, the activity of this enzyme is extremely important to understand in order to design safe and effective drug regimens.
Alternative Names
Glutamic-Oxaloacetic Transaminase 2; Kynurenine Aminotransferase IV; Plasma Membrane-Associated Fatty Acid-Binding Protein; Glutamic-Oxaloacetic Transaminase 2, Mitochondrial; Kynurenine--Oxoglutarate Transaminase IV; Kynurenine--Oxoglutarate Transaminase 4; Glutamate Oxaloacetate Transaminase 2; Kynurenine Aminotransferase 4; Aspartate Aminotransferase 2; Fatty Acid-Binding Protein; Aspartate Transaminase 2; Transaminase A; EC 2.6.1.1; CYP3A4; Aspartate aminotransferase; mitochondrial; mAspAT; Fatty acidbinding protein; FABP-1; Glutamate oxaloacetate transaminase 2; Kynurenine aminotransferase 4; Kynurenine aminotransferase IV; Kynurenine--oxoglutarate transaminase 4; Kynu
Background
This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases that catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and its expression is induced by glucocorticoids and some pharmacological agents. This enzyme is involved in the metabolism of approximately half the drugs in use today, including acetaminophen, codeine, cyclosporin A, diazepam, erythromycin, and chloroquine. The enzyme also metabolizes some steroids and carcinogens. This gene is part of a cluster of cytochrome P450 genes on chromosome 7q21.1. Previously another CYP3A gene, CYP3A3, was thought to exist; however, it is now thought that this sequence represents a transcript variant of CYP3A4. Alternatively spliced transcript variants encoding different isoforms have been identified.
Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets
Intracellular, Membrane (different isoforms)
Group enriched (Hepatocytes, Proximal enterocytes)
Not detected in immune cells
Cell line enhanced (BEWO, NB-4, RPMI-8226, SCLC-21H, SH-SY5Y)
Interacts with PGRMC1; the interaction requires PGRMC1 homodimerization.
Monooxygenase, Oxidoreductase
Anti-CYP3A4 rAb Products
Our anti-CYP3A4 recombinant antibodies are engineered for high specificity and are carefully validated to accurately detect the CYP3A4 enzyme in your samples, with selectivity even over the highly homologous CYP3A5 and CYP3A7. Optimized for use in Western Blot of liver microsomes, IHC, and in development of drug inhibition assays, our rAbs are designed to offer the reliability and precision required in advanced pharmacological research.
Table 1. Featured anti-CYP3A4 recombinant antibody products at Creative Biolabs.
| Cat. No. | Product Name | Target Species | Host Species | Applications |
| ZG-0632J | Rabbit Anti-CYP3A4 Recombinant Antibody (clone 10B10) | Human | Rabbit IgG | ELISA, IHC |
| VS3-QX314 | Mouse Anti-CYP3A4 Recombinant Antibody (clone 3H8) | Human | Mouse IgG1 | WB, IHC, ICC, FC, ELISA |
Creative Quality Control
Creative Biolabs takes scientific quality very seriously. The manufacturing of our anti-CYP3A4 recombinant antibodies is regulated by a rigorous quality assurance system. Every lot is validated and tested for purity, high isoform specificity, and consistent performance in validated applications.
Fig.1 IHC analysis of anti-CYP3A4 antibody
(Cat# ZG-0632J, Creative Biolabs).
Customer Reviews
Rabbit Anti-CYP3A4 Recombinant Antibody (clone 10B10)
rAb Production
Creative Biolabs is proud to support the specialized scientific field of pharmacology with its state-of-the-art production platforms. Our anti-CYP3A4 recombinant antibodies are expressed in optimized systems that ensure the recognition of the native enzyme and a specific, active research tool.
Featured Anti-CYP3A4 Recombinant Antibody Production Platforms
Fig.2 Milligram-scale anti-CYP3A4 recombinant antibody production.
Fig.3 Gram-scale anti-CYP3A4 recombinant antibody production.
rAb Modalities
Creative Biolabs is committed to supporting scientific progress by providing a wide range of flexible antibody solutions. Our anti-CYP3A4 recombinant antibodies are available in a variety of customizable modalities, so you can find the right tool for your research needs.
Fig.4 Full-length anti-CYP3A4 recombinant antibody production and modalities.
Dissect the mechanisms of metabolism with superior anti-CYP3A4 recombinant antibodies from Creative Biolabs. Our comprehensive portfolio features the validated specificity you need to study this key drug metabolizer enzyme in drug development and clinical pharmacology. Trust Creative Biolabs to provide the foundation for your research. Connect with our experts today.

